BE1001748A4 - Compositions pharmaceutiques pour l'administration par voie nasale. - Google Patents

Compositions pharmaceutiques pour l'administration par voie nasale. Download PDF

Info

Publication number
BE1001748A4
BE1001748A4 BE8700893A BE8700893A BE1001748A4 BE 1001748 A4 BE1001748 A4 BE 1001748A4 BE 8700893 A BE8700893 A BE 8700893A BE 8700893 A BE8700893 A BE 8700893A BE 1001748 A4 BE1001748 A4 BE 1001748A4
Authority
BE
Belgium
Prior art keywords
sep
sms
composition according
administration
nasal
Prior art date
Application number
BE8700893A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1001748A4 publication Critical patent/BE1001748A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BE8700893A 1986-08-18 1987-08-10 Compositions pharmaceutiques pour l'administration par voie nasale. BE1001748A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds

Publications (1)

Publication Number Publication Date
BE1001748A4 true BE1001748A4 (fr) 1990-02-27

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700893A BE1001748A4 (fr) 1986-08-18 1987-08-10 Compositions pharmaceutiques pour l'administration par voie nasale.

Country Status (24)

Country Link
KR (1) KR880002537A (pt)
AT (1) AT396331B (pt)
AU (2) AU612589B2 (pt)
BE (1) BE1001748A4 (pt)
CA (1) CA1322331C (pt)
CH (1) CH672252A5 (pt)
CS (1) CS411491A3 (pt)
DE (1) DE3726517A1 (pt)
DK (1) DK428287A (pt)
ES (1) ES2004807A6 (pt)
FI (1) FI93307C (pt)
FR (1) FR2602680B1 (pt)
GR (1) GR871289B (pt)
HK (1) HK80493A (pt)
HU (1) HU200940B (pt)
IE (1) IE60761B1 (pt)
IL (1) IL83572A (pt)
IT (1) IT1222510B (pt)
LU (1) LU86971A1 (pt)
NL (1) NL8701874A (pt)
NO (1) NO175519C (pt)
NZ (1) NZ221473A (pt)
PT (1) PT85545B (pt)
SE (1) SE8703183L (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1485117A4 (en) 2002-01-22 2006-03-22 Univ New York METHOD FOR THERAPEUTIC TREATMENT OF BENIGN PROSTATE HYPERTROPHY (BPH)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0029579A1 (en) * 1979-11-27 1981-06-03 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
EP0122036A1 (en) * 1983-03-09 1984-10-17 Teijin Limited Powdery pharmaceutical composition for nasal administration
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
EP0203031A2 (en) * 1985-04-25 1986-11-26 The Administrators of The Tulane University Educational Fund Biologically active lysine containing octapeptides
GB2176105A (en) * 1985-06-04 1986-12-17 Sandoz Ltd Nasal pharmaceutical compositions
EP0215171A2 (en) * 1985-09-12 1987-03-25 The Administrators Of The Tulane University Educational Fund Peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0029579A1 (en) * 1979-11-27 1981-06-03 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
EP0122036A1 (en) * 1983-03-09 1984-10-17 Teijin Limited Powdery pharmaceutical composition for nasal administration
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
EP0203031A2 (en) * 1985-04-25 1986-11-26 The Administrators of The Tulane University Educational Fund Biologically active lysine containing octapeptides
GB2176105A (en) * 1985-06-04 1986-12-17 Sandoz Ltd Nasal pharmaceutical compositions
EP0215171A2 (en) * 1985-09-12 1987-03-25 The Administrators Of The Tulane University Educational Fund Peptides

Also Published As

Publication number Publication date
KR880002537A (ko) 1988-05-09
NZ221473A (en) 1990-08-28
IT8721670A0 (it) 1987-08-18
NO175519C (no) 1994-10-26
FR2602680B1 (fr) 1993-04-16
IL83572A (en) 1992-09-06
SE8703183D0 (sv) 1987-08-17
ES2004807A6 (es) 1989-02-01
LU86971A1 (fr) 1988-03-02
AT396331B (de) 1993-08-25
NO175519B (no) 1994-07-18
ATA206087A (de) 1992-12-15
PT85545A (en) 1987-09-01
SE8703183L (sv) 1988-02-19
CA1322331C (en) 1993-09-21
IE872187L (en) 1988-02-18
NO873452D0 (no) 1987-08-17
DK428287A (da) 1988-02-19
IE60761B1 (en) 1994-08-10
FI93307C (fi) 1995-03-27
IT1222510B (it) 1990-09-05
NO873452L (no) 1988-02-19
FI93307B (fi) 1994-12-15
FI873548A0 (fi) 1987-08-17
AU637530B2 (en) 1993-05-27
AU8568991A (en) 1991-12-05
AU612589B2 (en) 1991-07-18
DK428287D0 (da) 1987-08-17
AU7712087A (en) 1988-02-25
FI873548A (fi) 1988-02-19
DE3726517A1 (de) 1988-03-03
PT85545B (pt) 1990-05-31
NL8701874A (nl) 1988-03-16
GR871289B (en) 1987-12-18
CH672252A5 (pt) 1989-11-15
HU200940B (en) 1990-09-28
HUT46235A (en) 1988-10-28
CS411491A3 (en) 1992-06-17
HK80493A (en) 1993-08-13
FR2602680A1 (fr) 1988-02-19
IL83572A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
US5846983A (en) Colonic delivery of nicotine to treat inflammatory bowel disease
JP4499282B2 (ja) 混合ミセル状薬剤の移送システム及び調製方法
EP1246668B1 (en) An rapid acting freeze dired oral pharmaceutical composition for treating migraine
Ramadas et al. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats
RU2436565C2 (ru) Распадающиеся пероральные пленки
TW416854B (en) Buccal delivery of glucagon-like insulinotropic peptides
AU753478B2 (en) Pharmaceutical formulations
KR102121443B1 (ko) 저혈당증의 치료를 위한 비강 분말 제제
FR2582511A1 (fr) Systeme d'application endonasal
GB2193891A (en) Nasal pharmaceutical compositions containing octreotide
EP2670368A1 (en) New oral dissolving films for insulin administration, for treating diabetes
JPH09504015A (ja) 活性物質を迅速に又は制御された態様で放出する非常に効果的なスルホニル尿素製剤及びそれらの製造方法
BE1001748A4 (fr) Compositions pharmaceutiques pour l'administration par voie nasale.
EP1009406B1 (fr) Composition pharmaceutique pour l'administration de thiocolchicoside a travers la muqueuse buccale
KR20130123659A (ko) 물성 및 쓴맛 차폐효과가 향상된 실데나필 경구용 속용 필름
Okeke Formulation of novel buccal mucosal drug delivery systems for nicotine replacement therapy (NRT)
CN113197854A (zh) 一种氟康唑三元纳米胶束及其制备方法
MXPA98003137A (en) Mouth-release of insulinotropic peptides like gluca

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19960831